Why Is Nektar (NKTR) Stock Up 17% Premarket Today? Positive AD Trial Data

Nektar stock jumped more than 17% in premarket trading after the company reported positive 52-week data from its REZOLVE-AD atopic dermatitis trial. source: https://tokenist.com/why-is-nektar-nktr-stock-up-17-premarket-today-positive-ad-trial-data/?utm_source=rss&utm_medium=rss&utm_campaign=why-is-nektar-nktr-stock-up-17-premarket-today-positive-ad-trial-data